104 related articles for article (PubMed ID: 8713790)
1. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
[TBL] [Abstract][Full Text] [Related]
2. The Fab-fragment of a PAI-1 inhibiting antibody reduces thrombus size and restores blood flow in a rat model of arterial thrombosis.
van Giezen JJ; Wahlund G; Nerme ; Abrahamsson T
Thromb Haemost; 1997 May; 77(5):964-9. PubMed ID: 9184411
[TBL] [Abstract][Full Text] [Related]
3. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
4. Enhanced fibrinolytic potential in mice with combined homozygous deficiency of alpha2-antiplasmin and PAI-1.
Dewerchin M; Collen D; Lijnen HR
Thromb Haemost; 2001 Aug; 86(2):640-6. PubMed ID: 11522016
[TBL] [Abstract][Full Text] [Related]
5. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
Lijnen HR; Stassen JM; Collen D
Thromb Haemost; 1995 May; 73(5):845-9. PubMed ID: 7482414
[TBL] [Abstract][Full Text] [Related]
7. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
[TBL] [Abstract][Full Text] [Related]
8. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
Lenfors S; Gustafsson D
Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
[TBL] [Abstract][Full Text] [Related]
9. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
Gómez C; Páramo JA; Colucci M; Rocha E
Thromb Haemost; 1989 Sep; 62(2):694-8. PubMed ID: 2683190
[TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate oligodeoxyribonucleotides antisense to PAI-1 mRNA increase fibrinolysis and modify experimental thrombosis in rats.
Pawlowska Z; Pluskota E; Chabielska E; Buczko W; Okruszek A; Stec WJ; Cierniewski CS
Thromb Haemost; 1998 Feb; 79(2):348-53. PubMed ID: 9493589
[TBL] [Abstract][Full Text] [Related]
11. S35225 is a direct inhibitor of Plasminogen Activator Inhibitor type-1 activity in the blood.
Rupin A; Gaertner R; Mennecier P; Richard I; Benoist A; De Nanteuil G; Verbeuren TJ
Thromb Res; 2008; 122(2):265-70. PubMed ID: 18177924
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a low molecular weight modulator of human plasminogen activator inhibitor-1 activity.
Charlton PA; Faint RW; Bent F; Bryans J; Chicarelli-Robinson I; Mackie I; Machin S; Bevan P
Thromb Haemost; 1996 May; 75(5):808-15. PubMed ID: 8725728
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of plasminogen activator inhibitor-1 accelerates thrombolysis of a platelet-rich thrombus in rat mesenteric arterioles.
Rupin A; Martin F; Vallez MO; Bonhomme E; Verbeuren TJ
Thromb Haemost; 2001 Dec; 86(6):1528-31. PubMed ID: 11776323
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
Hennan JK; Elokdah H; Leal M; Ji A; Friedrichs GS; Morgan GA; Swillo RE; Antrilli TM; Hreha A; Crandall DL
J Pharmacol Exp Ther; 2005 Aug; 314(2):710-6. PubMed ID: 15860572
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis.
Carmeliet P; Stassen JM; Schoonjans L; Ream B; van den Oord JJ; De Mol M; Mulligan RC; Collen D
J Clin Invest; 1993 Dec; 92(6):2756-60. PubMed ID: 8254029
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide attenuates thrombolysis in batroxobin-induced lung vasculature fibrin deposition but not in ferrous chloride-induced carotid artery thrombus in rats: role of endogenous PAI-1.
Wang YX; Dong N; Wu C; Martin-McNulty B; Fitch RM; da Cunha V; Vicelette J; Tran K; Vergona R; Sullivan ME; Morser J; Wu Q
Thromb Res; 2003; 111(6):381-7. PubMed ID: 14698657
[TBL] [Abstract][Full Text] [Related]
17. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
[TBL] [Abstract][Full Text] [Related]
18. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects due to pharmacological modulation of thrombin-activatable fibrinolysis inhibitor in rats.
Soni H; Sharma A; Bhatt S; Jain MR; Patel PR
Pharmacology; 2008; 82(4):304-9. PubMed ID: 18936552
[TBL] [Abstract][Full Text] [Related]
20. Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation.
Hellebrekers BW; Trimbos-Kemper GC; Bakkum EA; Trimbos JB; Declerck PJ; Kooistra T; Emeis JJ
Thromb Haemost; 2000 Nov; 84(5):876-81. PubMed ID: 11127871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]